InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,321.41
(
0.25%
)
US TECH 100
18,240.00
(
0.04%
)
Dow Jones
39,872.99
(
0.00%
)
Brent Oil
81.99
(
-0.56%
)
Bitcoin
69,984.73
(
-0.21%
)
Post# of 251889
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 188340

Sunday, 03/08/2015 12:48:26 PM

Sunday, March 08, 2015 12:48:26 PM

Post# of 251889
Re: Zarxio sales forecast in the US
Neupogen FoBs are great success in Europe and Zarzio is in the lead. In the US, Teva's version of Neupogen entered the market over a year ago but it isn't a real competitor as you know. Zarxio will do a lot better when it will enter, say 30% market share. Of course, if NVS can get pharmacy-level interchangeability sales will shot up. What will it take and how long before this happens?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up